Class IITerminatedD-1189-2022
Drug recall · July 20, 2022
Draximage MAA recall
Why: Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.
- Lots / codes
Lot # 1H005, exp. date Nov 30, 2023
- Quantity
- 519 cartons/30 vials each
- Company
- Jubilant Draximage Inc, Kirkland
- Distribution
- Product was distributed to retailers nationwide.
- Initiated
- June 16, 2022 · Voluntary: Firm initiated
- Classified
- July 8, 2022
- Reported
- July 20, 2022
- Ended
- July 25, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.